Upregulation of Mu Opioid Receptors by Voluntary Morphine Administration in Drinking Water
Morphine was provided to rats in drinking water for 21 days. Profound analgesic tolerance was detected both in hot-plate and tail-flick tests. The density of [3H]DAMGO binding sites increased by 76% in spinal cord membranes due to morphine exposure compared to those in opioid naive animals. Slightly augmented [3H]DAMGO binding was measured in the synaptic plasma membranes, with a concomitant decrease in the microsomal membranes, of morphine tolerant/dependent brains. These observations suggest that the regulation of spinal mu opioid receptors might be different from those in the brain. It is emphasized that the molecular changes underlying tolerance/dependence are influenced by several factors, such as the tissue or subcellular fractions used, besides the obvious importance of the route of drug administration. Results obtained after voluntary morphine intake further support the growing number of experimental data that chronic morphine does not internalize/downregulate the mu opioid receptors in the central nervous system.
KeywordsOpioid upregulation tolerance morphine spinal cord
Unable to display preview. Download preview PDF.
The interest and helpful comments of Mária Wollemann are highly appreciated. Thanks are due to Mrs. Ildikó Dobos for excellent technical assistance. This work was supported by OTKA T-033062, T-34741 and ETT 042/2001 research funds.
- 6.Cox, B. M. (1993) Opioid receptor-G protein interactions: acute and chronic effects of opioids. In: Born et al. (eds) Handbook of Exp. Pharmacol. Opioids I. Springer-Verlag, London, 145–188.Google Scholar
- 19.Seevers, M. H., Deneau, G. A. (1963) Physiological aspects of tolerance and physical dependence. In: Root, W. S., Hoffmann, F. G. (eds) Physiological Pharmacology. Academic Press, New York, 565–640.Google Scholar
- 23.Taylor, D. A., Fleming, W. W. (2000) Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J. Pharmacol. Exp. Therap. 297, 11–18.Google Scholar
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.